- Home
- EWTX vs BTE Comparison
EWTX vs BTE Comparison
Compare EWTX & BTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EWTX | BTE |
|---|---|---|
| Founded | 2017 | 1993 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Meat/Poultry/Fish |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.5B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | EWTX | BTE |
|---|---|---|
| Price | $24.12 | $3.39 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $34.13 | N/A |
| AVG Volume (30 Days) | 1.8M | ★ 15.6M |
| Earning Date | 03-02-2026 | 03-03-2026 |
| Dividend Yield | N/A | ★ 1.95% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $2,194,819,404.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $16.85 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.60 | $1.36 |
| 52 Week High | $30.48 | $3.42 |
Technical Indicators
Market Signals| Indicator | EWTX | BTE |
|---|---|---|
| Relative Strength Index (RSI) | 52.10 | 63.57 |
| Support Level | $22.78 | $3.04 |
| Resistance Level | $25.41 | $3.34 |
| Average True Range (ATR) | 1.90 | 0.13 |
| MACD | -0.09 | 0.01 |
| Stochastic Oscillator | 58.18 | 93.18 |
Price Performance
Historical ComparisonAbout EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.
About BTE Baytex Energy Corp
Baytex Energy Corp is an oil and gas company. Geographically, the group operates in Canada and the United States. The company derives a majority of revenue from Canada. Its Canada segment includes the exploration, development, and production of crude oil and natural gas in Western Canada.